HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Expression of prostaglandin transporter in colorectal cancer tissues and its relationship with clinicopathological features].

AbstractOBJECTIVE:
To investigate the expression of prostaglandin transporter (PGT) in colorectal cancer (CRC) tissues and its relationship with clinicopathological features.
METHODS:
The mRNA and protein levels of PGT were determined by real-time PCR, Western blot and immunohistochemical methods in cancer tissues and adjacent normal tissue from 80 patients with colorectal cancer and their relationship with clinicopathological features was analyzed.
RESULTS:
Compared with the adjacent normal tissue of colorectal cancer, the PGT mRNA relative expression (0.57 ± 0.33 vs. 2.33 ± 1.20) and the PGT protein expression in cancer tissues decreased significantly [PGT/GAPDH 0.45 ± 0.16 vs. 0.78 ± 0.23, integral A 718.7 ± 359.4 vs. 10412.0 ± 6423.3, average A 0.03 ± 0.01 vs. 0.12 ± 0.09, all P<0.01]. Lower mRNA and protein expressions of PGT in colorectal cancer were associated with depth of invasion T3 to T4 and TNM stage III( to IIII( (P<0.01), while not associated with gender, age, tumor location and differentiation degree (all P>0.05).
CONCLUSION:
Expression levels of PGT mRNA and protein in colorectal cancer tissue are significantly down-regulation. PGT expression is associated with invasion depth and late stages.
AuthorsShanliang Shang, Xiujun Liao, Zhong Shen, Jianming Qiu, Shuxian Shao, Lie Ding, Dong Wang, Guangen Yang, Yanxiang Zhang
JournalZhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery (Zhonghua Wei Chang Wai Ke Za Zhi) Vol. 18 Issue 3 Pg. 277-81 (Mar 2015) ISSN: 1671-0274 [Print] China
PMID25809334 (Publication Type: Journal Article)
Chemical References
  • Organic Anion Transporters
  • RNA, Messenger
  • SLCO2A1 protein, human
Topics
  • Colorectal Neoplasms
  • Down-Regulation
  • Humans
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Organic Anion Transporters
  • RNA, Messenger

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: